Test Code 2058
New York approved

Autosomal Dominant Polycystic Kidney Disease via MLPA of PKD1

PKD1

2 - 3 weeks (6 - 11 days STAT)

Who is this test for?
  • Individuals with a clinical or suspected diagnosis of autosomal dominant polycystic kidney disease (ADPKD) especially when the sequencing test is negative
  • Individuals with a clinical or suspected diagnosis of TSC2/PKD1 contiguous gene deletion syndrome
  • Family members of individuals with known copy number variants (deletions or duplications) affecting PKD1
Method
Multiplex Ligation-Dependent Probe Amplification Assay
Specimen(s)

Blood, Buccal

Order Options

OTHER OPTIONS
for pricing.

Explore related tests

Questions? We can help.

Getting support has never been easier. Connect with our team for assistance with anything from test selection to interpreting results. Use the live chat button or visit our Contact us page.

    Autosomal Dominant Polycystic Kidney Disease via MLPA of PKD1 | Prevention Genetics